Virus News and Research

Latest Virus News and Research

Scientists map key elements of immune overreaction triggered by influenza virus infection

Scientists at The Scripps Research Institute (TSRI) have mapped key elements of a severe immune overreaction—a "cytokine storm"—that can both sicken and kill patients who are infected with certain strains of flu virus.

3 Mar 2014

Researchers identify mutations in gene that can reduce risk of developing type 2 diabetes

An international team led by researchers at the Broad Institute and Massachusetts General Hospital (MGH) has identified mutations in a gene that can reduce the risk of developing type 2 diabetes, even in people who have risk factors such as obesity and old age.

3 Mar 2014

Longer looks: A doctor struggles with new health system; how to reduce end-of-life costs; fighting cancer with aspirin

I know how lucky I am to be a patient who happens to also work in the healthcare system. ... Initially, I had to use antibiotic drops every hour. But my insurance would only cover one three-milliliter bottle every three weeks. Each bottle not covered by insurance cost me $130. ... My own experience makes me fear that for many Americans, health insurance may not necessarily equal health care. Access and cost will still remain barriers - and can be difficult to surmount for many (Dr. Helen Ouyang, 2/24)

28 Feb 2014

Scientists develop new anti-viral drugs that may be effective against flu virus

New analysis of the influenza A virus by scientists at the University of Hertfordshire shows potential for developing new anti-viral drugs which are more likely to be universally effective against the flu virus originating from avian, swine or human virus strains.

28 Feb 2014

TSRI scientists describe severe immune overreaction caused by flu infections

Scientists at The Scripps Research Institute have mapped key elements of a severe immune overreaction—a “cytokine storm”—that can both sicken and kill patients who are infected with certain strains of flu virus.

28 Feb 2014

Researchers develop new method for rapid detection of anthrax

Shortly following the 9/11 terror attack in 2001, letters containing anthrax spores were mailed to news outlets and government buildings killing five people and infecting 17 others.

28 Feb 2014

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today reported financial results for the three months and year ended December 31, 2013, and provided an update of recent corporate developments.

27 Feb 2014

Study: Direct camel-to-human transmission of MERS virus is possible in Saudi Arabia

An estimated three-quarters of camels recently surveyed in Saudi Arabia have evidence of infection with the Middle East Respiratory Syndrome coronavirus (MERS-CoV), the virus responsible for human cases of MERS.

27 Feb 2014

Researchers discover new target for human antibodies that holds key to vaccine for dengue

Creating a vaccine that protects people from all four types of dengue virus has frustrated scientists for decades. But researchers at the University of North Carolina have discovered a new target for human antibodies that could hold the key to a vaccine for the world's most widespread mosquito-borne disease.

27 Feb 2014

UNC receives $40M for clinical trials unit devoted to HIV/AIDS treatment, prevention and research

The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.

27 Feb 2014

Viewpoints: Finding a plan for 'tinkering with DNA'; fact-checking claims of ACA losses; pediatricians' fears of retail clinics

The manipulation of human genes could lead to profound advances in our ability to cure or prevent terrible diseases. But in some cases, it might also mean introducing genetic material that could be passed from one generation to the next, changing the human gene pool in a manner that could inadvertently harm peoples' health.

26 Feb 2014

Researchers discover how byproducts from bacteria prevalent in gum disease incite growth of deadly tumors

Researchers from Case Western Reserve University have discovered how byproducts in the form of small fatty acids from two bacteria prevalent in gum disease incite the growth of deadly Kaposi's sarcoma-related (KS) lesions and tumors in the mouth.

26 Feb 2014

Johns Hopkins researchers use tiny particles to train immune systems of mice to fight melanoma

Using tiny particles designed to target cancer-fighting immune cells, Johns Hopkins researchers have trained the immune systems of mice to fight melanoma, a deadly skin cancer. The experiments, described tk on the website of ACS Nano, represent a significant step toward using nanoparticles and magnetism to treat a variety of conditions, the researchers say.

26 Feb 2014

Researchers identify polio-like syndrome in cluster of children from California

Researchers have identified a polio-like syndrome in a cluster of children from California over a one-year period, according to a case report released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014.

25 Feb 2014

Coronavirus responsible for MERS is prevalent in camels throughout Saudi Arabia

The coronavirus responsible for Middle East Respiratory Syndrome (MERS) is prevalent in camels throughout Saudi Arabia and has been around for at least 20 years, according to a study to be published on February 25 in mBio-, the online open-access journal of the American Society for Microbiology.

25 Feb 2014

States: Calif. docs fight health law reimbursements; Wis. and collective bargaining; Kan. navigators restrictions

A selection of health policy stories from California, Wisconsin, Kansas, Virginia, Oregon, Georgia, North Carolina and Maine.

25 Feb 2014

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start.

25 Feb 2014

First Edition: February 24, 2014

Today's headlines include continuing coverage of Medicare Advantage payment rates, as well as a range of stories about the health law's Medicaid expansion and online insurance marketplaces.

24 Feb 2014

Scientists discover how viral DNA of HBV can be degraded in cell nucleus

Scientists from the Helmholtz Zentrum München and the Technische Universität München have discovered how the viral DNA of the hepatitis B virus (HBV) can be degraded in the cell nucleus of liver cells, consequently allowing the virus to be eliminated.

24 Feb 2014

Cell therapy: A powerful treatment for cancer patients

Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.

24 Feb 2014

Virus News and Research

Latest Virus News and Research

Scientists map key elements of immune overreaction triggered by influenza virus infection

Researchers identify mutations in gene that can reduce risk of developing type 2 diabetes

Longer looks: A doctor struggles with new health system; how to reduce end-of-life costs; fighting cancer with aspirin

Scientists develop new anti-viral drugs that may be effective against flu virus

TSRI scientists describe severe immune overreaction caused by flu infections

Researchers develop new method for rapid detection of anthrax

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Study: Direct camel-to-human transmission of MERS virus is possible in Saudi Arabia

Researchers discover new target for human antibodies that holds key to vaccine for dengue

UNC receives $40M for clinical trials unit devoted to HIV/AIDS treatment, prevention and research

Viewpoints: Finding a plan for 'tinkering with DNA'; fact-checking claims of ACA losses; pediatricians' fears of retail clinics

Researchers discover how byproducts from bacteria prevalent in gum disease incite growth of deadly tumors

Johns Hopkins researchers use tiny particles to train immune systems of mice to fight melanoma

Researchers identify polio-like syndrome in cluster of children from California

Coronavirus responsible for MERS is prevalent in camels throughout Saudi Arabia

States: Calif. docs fight health law reimbursements; Wis. and collective bargaining; Kan. navigators restrictions

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

First Edition: February 24, 2014

Scientists discover how viral DNA of HBV can be degraded in cell nucleus

Cell therapy: A powerful treatment for cancer patients

A new way of characterising biomolecules eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in